Research shows that a balanced combination of two omega fatty acids—DHA and ARA in a 1:1 ratio—significantly improved blood sugar control and liver health in pregnant mice with gestational diabetes. According to Gram Research analysis, this specific ratio reduced blood glucose, cholesterol, and inflammation markers more effectively than either fatty acid alone, suggesting it could be a promising natural approach for managing gestational diabetes in humans, though human studies are still needed.
Researchers studied how two types of healthy fats—DHA and ARA—might help pregnant women with gestational diabetes, a condition where blood sugar gets too high during pregnancy. According to Gram Research analysis, when these fats were combined in specific ratios, they helped lower blood sugar, reduce harmful cholesterol, and decrease inflammation in mice with gestational diabetes. The best results came from equal amounts of both fats (1:1 ratio) or more ARA than DHA (1:4 ratio). These findings suggest that the right balance of these omega fatty acids could be a natural way to manage blood sugar problems during pregnancy, though more human studies are needed.
Key Statistics
A 2026 research study found that mice with gestational diabetes receiving equal parts DHA and ARA (1:1 ratio) showed significantly lower blood glucose, total cholesterol, and triglyceride levels compared to mice receiving only one fatty acid or other ratios.
According to a 2026 analysis published in NPJ Science of Food, the 1:1 DHA:ARA ratio intervention changed 21 different liver chemicals in gestational diabetic mice, including increasing protective compounds like hypotaurine and guanine while decreasing harmful L-isoleucine.
Research from 2026 demonstrated that both the 1:1 and 1:4 DHA:ARA ratios reduced oxidative stress and inflammatory responses in pregnant mice with gestational diabetes while improving liver tissue health and structure.
The Quick Take
- What they studied: Whether different combinations of two omega fatty acids (DHA and ARA) could help control blood sugar and improve liver health in pregnant mice with gestational diabetes.
- Who participated: Laboratory mice with gestational diabetes were divided into groups receiving different amounts and ratios of DHA and ARA fatty acids, compared to untreated diabetic mice.
- Key finding: Mice receiving equal parts DHA and ARA (1:1 ratio) or more ARA than DHA (1:4 ratio) had significantly lower blood sugar, cholesterol, and triglycerides, plus less inflammation and healthier livers than other groups.
- What it means for you: This research suggests that pregnant women with gestational diabetes might benefit from supplements with balanced omega fatty acids, but human studies are still needed before doctors can recommend this treatment. Talk to your healthcare provider before taking any supplements during pregnancy.
The Research Details
Researchers created gestational diabetes in laboratory mice and then gave different groups various combinations of two omega fatty acids: DHA (found in fish oil) and ARA (found in eggs and meat). Some mice got only DHA, some got only ARA, and others got different mixtures—equal amounts of both, more DHA than ARA, or more ARA than DHA. The researchers then measured blood sugar levels, cholesterol, triglycerides, and inflammation markers in all the mice.
They also examined the livers under a microscope to see if the fatty acid combinations improved liver damage caused by gestational diabetes. Additionally, they performed advanced testing called metabolomics, which identifies hundreds of different chemicals in the liver to understand exactly how these fatty acids were working at a molecular level.
This type of study is important because it allows researchers to test treatments in a controlled environment before considering human trials. The mouse model of gestational diabetes closely mimics the human condition, making the findings potentially relevant to pregnant women.
Understanding which combination of omega fatty acids works best is crucial because gestational diabetes affects 2-10% of pregnancies and can cause serious complications for both mother and baby. If a simple, natural supplement could help control blood sugar during pregnancy, it could reduce the need for insulin injections and lower the risk of complications. This research identifies the specific ratios that appear most effective, which could guide future human studies and supplement development.
This study was published in a peer-reviewed scientific journal, meaning other experts reviewed the research before publication. However, this was an animal study using mice, not humans, so results may not directly apply to pregnant women. The researchers used detailed measurements and advanced laboratory techniques, which strengthens the findings. The study was relatively small in scope (specific sample size not provided), and the mechanisms identified in mice livers may work differently in human bodies. More research in humans is needed before making clinical recommendations.
What the Results Show
The most important finding was that mice receiving a 1:1 ratio of DHA to ARA (equal amounts) or a 1:4 ratio (more ARA) showed the best improvements in blood sugar control and liver health. These two ratios reduced blood glucose levels significantly compared to mice that received only DHA or only ARA. Both ratios also lowered total cholesterol, triglycerides (blood fats), and LDL cholesterol (the “bad” cholesterol), while reducing markers of inflammation and oxidative stress (cellular damage).
When researchers examined the livers under a microscope, mice receiving the 1:1 and 1:4 ratios showed much healthier liver tissue with less damage and scarring compared to untreated diabetic mice. The liver improvements were particularly notable because gestational diabetes often damages the liver’s ability to process fats and sugars.
The 1:1 ratio appeared slightly more effective at restoring normal liver chemistry, while the 1:4 ratio was nearly as effective. In contrast, mice receiving only DHA or only ARA showed much smaller improvements, suggesting that the combination and balance of these two fatty acids is what matters most.
The metabolomics analysis revealed that the 1:1 and 1:4 ratios changed the levels of 20-21 different chemicals in the liver. Specifically, beneficial chemicals like hypotaurine and guanine increased significantly, while harmful chemicals like L-isoleucine decreased. The 1:1 ratio uniquely restored a protective chemical called allantoin while reducing serine, which may have additional benefits for liver function. These chemical changes suggest that the fatty acid combinations work by fixing three main metabolic pathways: the production of branched-chain amino acids (building blocks for proteins), taurine metabolism (important for liver and heart health), and purine metabolism (involved in energy production and immune function).
Previous research has shown that DHA and ARA individually have some benefits for metabolic health, but this is among the first studies to systematically test different ratios of these two fatty acids together. Earlier studies suggested that omega-3 fatty acids like DHA help reduce inflammation, while ARA (an omega-6 fatty acid) supports brain and eye development—especially important during pregnancy. This research builds on that foundation by showing that the specific balance between these two fats matters more than having high amounts of either one alone. The finding that a 1:1 ratio works best aligns with some nutritional science suggesting that balanced omega-3 to omega-6 ratios support better metabolic health.
The most significant limitation is that this study used mice, not humans. Mice metabolize nutrients differently than people, and what works in mice doesn’t always work in humans. The study didn’t specify the exact number of mice used, making it harder to assess statistical reliability. The research was conducted in a laboratory setting with controlled diets and conditions, which differs from real-world pregnancy where diet, exercise, stress, and genetics vary widely. The study didn’t test whether these fatty acids would be safe or effective in actual pregnant women, and it didn’t examine potential side effects or interactions with other medications. Additionally, the study measured liver chemistry changes but didn’t determine whether these changes would actually prevent pregnancy complications in humans.
The Bottom Line
Based on this animal research, the 1:1 ratio of DHA to ARA appears most promising for managing gestational diabetes, with the 1:4 ratio as a close alternative. However, these findings are preliminary and come from mouse studies only. Pregnant women with gestational diabetes should not start taking DHA and ARA supplements based on this research alone. Instead, they should work with their healthcare provider to manage gestational diabetes through proven methods: dietary changes, regular physical activity, blood sugar monitoring, and insulin if needed. Future human clinical trials are necessary before doctors can recommend these specific fatty acid ratios during pregnancy.
This research is most relevant to pregnant women diagnosed with gestational diabetes who are looking for additional ways to manage their condition. Healthcare providers specializing in maternal health and nutrition should be aware of these findings as they may inform future treatment guidelines. Supplement manufacturers may use this research to develop new prenatal products, though such products would need rigorous human testing first. Women planning pregnancy who have risk factors for gestational diabetes (obesity, family history of diabetes, previous gestational diabetes) might find this research interesting but should not self-treat without medical guidance.
In the mouse studies, the improvements in blood sugar and liver health appeared within the timeframe of the experiment, but the exact duration wasn’t specified. If similar effects occur in humans, benefits would likely take several weeks to appear, similar to other dietary interventions. Pregnant women should expect that any treatment for gestational diabetes requires consistent use over time and works best combined with other lifestyle changes. Blood sugar improvements would need to be monitored regularly through standard medical testing.
Frequently Asked Questions
Can I take DHA and ARA supplements if I have gestational diabetes during pregnancy?
Do not start any supplements without consulting your healthcare provider first. While this mouse research suggests potential benefits from specific DHA:ARA ratios, human studies haven’t confirmed safety or effectiveness in pregnant women. Your doctor can recommend appropriate prenatal vitamins and discuss whether additional omega fatty acids are right for your situation.
What foods contain DHA and ARA that I can eat during pregnancy?
DHA is found in fatty fish (salmon, sardines), seaweed, and some prenatal vitamins. ARA occurs naturally in eggs, chicken, beef, and dairy products. Eating a variety of these foods provides both fatty acids, though the exact ratio varies by food. Always cook fish thoroughly and avoid high-mercury varieties during pregnancy.
How does the 1:1 ratio of DHA to ARA work to lower blood sugar?
The research shows this ratio improves three metabolic pathways in the liver: amino acid production, taurine metabolism, and purine metabolism. These pathways help the body process glucose more efficiently and reduce inflammation. However, the exact mechanisms in human pregnancy remain unclear and require further study.
Is this research ready to be used as a treatment for gestational diabetes?
No. This was an animal study in mice, not humans. While the results are promising, researchers must conduct clinical trials in pregnant women to confirm safety, effectiveness, and appropriate dosing before doctors can recommend this as a treatment. Current standard care includes diet, exercise, monitoring, and insulin if needed.
Could this research help prevent gestational diabetes if I’m at risk?
This study focused on treating existing gestational diabetes in mice, not prevention in humans. While omega fatty acids support general health, there’s no evidence yet that specific DHA:ARA ratios prevent gestational diabetes. Proven prevention strategies include maintaining a healthy weight, regular exercise, and balanced nutrition before and during pregnancy.
Want to Apply This Research?
- Track daily intake of DHA and ARA-rich foods (fatty fish, eggs, nuts, seeds) and correlate with weekly blood sugar readings if you have gestational diabetes. Log the specific foods and portion sizes to identify which combinations feel most manageable during pregnancy.
- If your healthcare provider approves, add one DHA-rich food (like salmon or sardines) and one ARA-rich food (like eggs or chicken) to your daily meals, aiming for balanced portions. Use the app to set reminders for meal planning and track how you feel after eating these foods.
- Create a weekly log of blood sugar readings, energy levels, and any digestive changes. Compare patterns across weeks to see if adding these fatty acids correlates with more stable blood sugar. Share this data with your healthcare provider at prenatal appointments to guide treatment decisions.
This research was conducted in laboratory mice and has not been tested in pregnant women. The findings are preliminary and should not be used as medical advice. Pregnant women with gestational diabetes should work with their healthcare provider to manage their condition using proven treatments including dietary modifications, physical activity, blood sugar monitoring, and medication if prescribed. Do not start any supplements, including DHA or ARA supplements, during pregnancy without explicit approval from your obstetrician or maternal health specialist. This article is for educational purposes only and does not replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.